Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)

Clinical Toxicology

Volumn 49, Issue 7, 2011, Pages 691-693

  Derungs, Adrian ^a   Schietzel, Simeon ^a   Meyer, Markus R ^b   Maurer, Hans H ^b   Krähenbühl, Stephan ^a   Liechti, Matthias E ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Amphetamine; CNS; Drug abuse; Pharmacokinetics; Stimulant

Indexed keywords

BROMAZEPAM; CATHINONE; NAPHTHYLPYROVALERONE; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ADULT; ANXIETY; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG DEPENDENCE; ELECTROCARDIOGRAPHY; HALLUCINATION; HUMAN; INSOMNIA; LABORATORY TEST; MALE; MASS FRAGMENTOGRAPHY; RESTLESSNESS; SUBSTANCE ABUSE;

ADULT; ANXIETY; HALLUCINATIONS; HUMANS; MALE; PENTANONES; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; PYRROLIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SYMPATHETIC NERVOUS SYSTEM;

EID: 80052488621     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.592838     Document Type: Article

References (15)

1. Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, et al. Mephedrone (4-methylmethcathinone; 'meow meow' ): chemical, pharmacological and clinical issues. Psychopharmacology 2011; 214:593-602.
2. Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F. Mephedrone, new kid for the chop? Addiction 2011; 106:154-161.
3. Carhart-Harris RL, King LA, Nutt DJ. A web-based survey on mephedrone. Drug Alcohol Depend 2011. doi: 10.1016/j.drugalcdep. 2011.02.011.
4. Brandt SD, Wootton RC, De Paoli G, Freeman S. The naphyrone story: the alpha or beta-naphthyl isomer? Drug Test Anal 2010; 2:496-502.
5. De Paoli G, Maskell PD, Pounder DJ. Naphyrone: analytical profi le of the new " legal high " substitute for mephedrone. J Forensic Leg Med 2011; 18:93.
6. Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantifi cation of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J Mass Spectrom 2003; 38:659-676. (Pubitemid 36818224)
7. Maurer HH, Pfl eger K, Weber AA. Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites. 5th revised ed. Weinheim: Wiley-VCH; 2011.
8. Maurer HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther Drug Monit 2010; 32:544-549.
9. Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2- pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 2006; 49:1420-1432. (Pubitemid 43271895)
10. Crew. Information sheet on naphyrone, sometimes sold as NRG-1. http://www.crew2000.org.uk/index.php?mact- Uploads,cntnt01,default, 0&cntnt01mode- single&cntnt01upload-id- 123&cntnt- 01category- Miscellaneous%20&cntnt01returnid- 95. Accessed 18 April 2011.
11. Dargan PI, Albert S, Wood DM. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010; 103:875-879.
12. Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011; 28:280-282.
13. Regan L, Mitchelson M, Macdonald C. Mephedrone toxicity in a Scottish emergency department. Emerg Med J 2010. doi: 10.1136/ emj.2010.103093.
14. Vaults. Time fl ies: naphythylpyrovalerone (NRG-1). . erowid.org/experiences/exp.php?ID- 85168. Accessed 8 April 2011.
15. EvE&Rave. Neometh & NRG-1, was soll das sein? . eve-rave.ch/Forum/viewtopic.php?f- 53&t- 18935&start- 50. Accessed 18 April 2011.